# Havah Therapeutics, Inc. — Form D

Havah Therapeutics, Inc. of LONGMONT, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-30. The offering totals $507K, of which $507K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-05-30
- Form: D
- Accession: 0002025011-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $507K
- Amount sold: $507K
- Investors: 14
- Date of first sale: 2024-05-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-514623

## Issuer

- Name: Havah Therapeutics, Inc.
- CIK: 0002025011
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2112 ANDREW ALDEN ST, LONGMONT, CO, 80504
- Phone: 3037179446

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Matthew Brewer | Director | Aurora, CO |
| Ronald Martell | Director | Houston, TX |
| Jim Weiss | Director | Longmont, CO |
| Matthew Brewer | Executive Officer | Aurora, CO |

## More

- [CIK 2025011 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2025011&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002025011-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.